Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q92769 (HDAC2_HUMAN) Homo sapiens (Human)

Histone deacetylase 2 UniProtKBInterProSTRINGInteractive Modelling

488 aa; Sequence (Fasta) ; (Isoform 3); 4 identical sequences: Pan troglodytes: K7B9A4, A0A803KJY1; Gorilla gorilla gorilla: G3QRQ8; Piliocolobus tephrosceles: A0A8C9HY57

Available Structures

39 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cryo-EM structure of the human SIN3B histone deacetylase core complex with SAHA at 2.8 Angstrom Heteromer
O75182; Q96QT6;
8-375
SHH;ZN;CA;
Assess
Cryo-EM structure of the human SIN3B histone deacetylase complex at 3.7 Angstrom Heteromer
O75182; Q96QT6; Q9UBU8;
8-375
ZN;CA;
Assess
Cryo-EM structure of the human SIN3B full-length complex at 3.4 Angstrom resolution Heteromer
O75182; Q96QT6; Q9UBU8;
8-375
ZN;CA;
Assess
Cryo-EM structure of the human SIN3B histone deacetylase core complex at 2.8 Angstrom Heteromer
O75182; Q96QT6;
8-375
ZN;CA;ACT;
Assess
Histone deacetylases complex with peptide macrocyclesmonomer2-375
ZN;NA;NHE;PG4;PGE;PEG;
Assess
Histone deacetylases complex with peptide macrocyclesmonomer2-375
ZN;NA;NHE;PG4;PGE;
Assess
Histone deacetylases complex with peptide macrocyclesmonomer2-375
ZN;NA;NHE;PGE;PG4;
Assess
Histone deacetylases complex with peptide macrocyclesmonomer4-375
ZN;NA;NHE;PGE;PG4;
Assess
Histone deacetylases complex with peptide macrocyclesmonomer3-374
ZN;NA;PGE;
Assess
Structure of HDAC2 complexed with an inhibitory ligandmonomer7-375
ZN;CA;NA;PGE;EDO;KJ6;2OP;
Assess
Ligand binding to HDAC2monomer7-375
ZN;CA;NA;PEG;PGE;KJF;
Assess
HDAC2 WITH LIGAND BRD7232monomer7-375
ZN;CA;6EZ;PEG;PG4;PG5;PGE;
Assess
Inhibitor binding to HDAC2monomer7-375
ZN;CA;NA;PEG;KRU;
Assess
HDAC2 complexed with an inhibitory ligandmonomer7-375
ZN;CA;NA;PEG;EDO;SHH;KK0;
Assess
HDAC2 in complex with inhibitory ligandmonomer7-375
ZN;CA;NA;EDO;KJN;
Assess
Crystal structure of human HDAC2 in complex with (R)-6-[3,4-Dioxo-2-(4-trifluoromethoxy-phenylamino…monomer7-375
ZN;CA;NA;EL8;
Assess
Structure of Human HDAC2 in complex with a 2-substituted benzamide inhibitor (compound 20)monomer8-375
ZN;CA;SO4;PEG;WBA;
Assess
Structure of Human HDAC2 in complex with an ethyl ketone inhibitor containing a spiro-bicyclic groupmonomer8-375
ZN;SO4;CA;PEG;TV7;
Assess
STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH KETONE INHIBITOR (COMPOUND E)monomer8-375
ZN;SO4;CA;PEG;V1P;
Assess
Structure of HDAC2 in complex with an inhibitor (compound 9)monomer8-375
ZN;SO4;CA;PEG;V1P;
Assess
Structure of HDAC2 in complex with a macrocyclic inhibitor (compound 25)monomer8-375
ZN;SO4;CA;PEG;ZL4;
Assess
STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH AN ARYL KETONE INHIBITORmonomer8-375
ZN;CA;SO4;PEG;V1D;
Assess
Structure of Human HDAC2 in complex with inhibitor 4-(acetylamino)-N-[2-amino-5-(thiophen-2-yl)phen…monomer8-375
ZN;CA;NA;PG4;20Y;
Assess
STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH AN ETHYL KETONE INHIBITOR CONTAINING A SPIRO-BICYCLIC GROU…monomer8-375
ZN;SO4;CA;PEG;VJV;
Assess
HDAC2 WITH LIGAND BRD4884monomer8-375
ZN;CA;IWX;PG5;PGE;
Assess
Structure of HDAC2 in complex with an inhibitor (compound 14)monomer8-375
ZN;SO4;CA;PEG;ZLS;
Assess
STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH KETONE INHIBITOR (COMPOUND O)monomer8-375
ZN;SO4;CA;PEG;V1S;
Assess
Structure of HDAC2 in complex with a macrocyclic inhibitor (compound 4)monomer8-375
ZN;SO4;CA;PEG;ZLV;
Assess
Structure of HDAC2 in complex with an inhibitor (compound 19)monomer8-375
ZN;SO4;CA;PEG;ZLM;
Assess
Structure of Human HDAC2 in complex with SAHA (vorinostat)monomer8-375
ZN;CA;NA;PG4;SHH;
Assess
HDAC2 in complex with an inhibitormonomer8-375
ZN;CA;NA;KIZ;
Assess
Structure of Human HDAC2 in complex with a 2-substituted benzamide inhibitor (compound 16)monomer8-375
ZN;CA;PEG;WB4;
Assess
Structure of Human HDAC2 in complex with an ethyl ketone inhibitormonomer8-374
TV1;ZN;CA;PEG;
Assess
STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH AN INHIBITOR LACKING A ZINC BINDING GROUP (COMPOUND 19)monomer8-374
ZN;SO4;CA;ACT;PEG;YEV;
Assess
STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH AN INHIBITOR THAT LACKS A ZINC BINDING GROUP (COMPOUND 12)monomer8-374
ZN;CA;ACT;PEG;YEM;
Assess
Ligand binding to HDAC2monomer9-375
PEG;PG4;EDO;ZN;CA;NA;KKW;KZF;
Assess
STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH APICIDINmonomer8-374
ZN;CA;PEG;YED;
Assess
Inhibitory Ligand binding to HDAC2monomer10-375
EDO;PG4;PEG;ZN;CA;NA;KKI;NHE;
Assess
Crystal Structure of Human HDAC2 complexed with an N-(2-aminophenyl)benzamidemonomer9-374
ZN;CA;NA;LLX;NHE;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7zzo.1.Amonomer0.898-375
ZN;CA;KIZ;100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 37zzu.3.Amonomer0.881-345
ZN;CA;KKI;100.00
Assess